Additional resources
Cancer immunotherapy biomarker testing – what pathologists need to know
Cancer immunotherapy has revolutionized the field of oncology. Based on a recently published article by Roche Tissue Diagnostics Chief Medical Officer Eric Walk, MD, "The Cancer Immunotherapy Biomarker Testing Landscape," this summary by the College of American Pathologists outlines those cancer immunotherapy biomarkers that are in routine use as a resource for individualized test selection in clinical pathology practice.
10 reasons the PD-L1 biomarker is transforming tumor testing
When looking for ways to make more informed, data-driven decisions, companion diagnostics present a promising way forward for personalized healthcare. Here are 10 reasons the expanding application of this predictive assay is ideal for future-focused labs looking for a sustainable PD-L1 diagnostic solution.
White paper
U DISCOVERY 5-Plex IF procedure: A fully automated immunofluorescence multiplex solution.
IHC detection guide for DISCOVERY platforms
Poster detailing IHC detection and amplification menu for DISCOVERY platforms.
Discover your research potential
Brochure on fully automated multiplex staining with DISCOVERY ULTRA staining system.